학술논문
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study
Document Type
Article
Author
Martin, T.G.; Moreau, P.; Usmani, S.Z.; Garfall, A.; Mateos, M.-V.; San-Miguel, J.F.; Oriol, A.; Nooka, A.K.; Rosinol, L.; Chari, A.; Karlin, L.; Krishnan, A.; Bahlis, N.; Popat, R.; Besemer, B.; Martínez-López, J.; Delforge, M.; Trancucci, D.; Pei, L.; Kobos, R.; Fastenau, J.; Gries, K.S.; van de Donk, N.W.C.J.
Source
In: Clinical Lymphoma, Myeloma and Leukemia . (Clinical Lymphoma, Myeloma and Leukemia, March 2024, 24(3):194-202)
Subject
Language
English
ISSN
21522669
21522650
21522650